Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 159 M— — Research & development 92 M— — Operating income 272 M-227 M — Non-Operating Income, Total 1 M3 M — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses 03 M — Unusual income/expense 1 M— — Pretax income 272 M1.41 B — Equity in earnings 15 M— — Taxes 49 M245 M — Non-controlling/minority interest 12 M— — After tax other income/expense —— — Net income before discontinued operations 211 M1.16 B — Discontinued operations —— — Net income 211 M1.16 B — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 211 M1.16 B — Basic earnings per share (Basic EPS) 1.01— — Diluted earnings per share (Diluted EPS) 1.015.53 — Average basic shares outstanding 209 M209.6 M — Diluted shares outstanding 209 M209.8 M — EBITDA 367 M— — EBIT 273 M— — Cost of revenue 701 M— — Other cost of goods sold —— — Depreciation & amortization (cash flow) 94 M207 M —